Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cain

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Growth Factors (Chur, Switzerland)|June 28, 2011
Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinitiesStephen P Berasi, Usha Varadarajan, Joanne Archambault, et al.
Biochemistry|February 25, 2015
Characterization of binding mode of action of a blocking anti-platelet-derived growth factor (PDGF)-B monoclonal antibody, MOR8457, reveals conformational flexibility and avidity needed for PDGF-BB to bind PDGF receptor-βJun Kuai, Lidia Mosyak, Jon Brooks, et al.
Gene|February 6, 2007
Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signalingBheem M Bhat, Kristina M Allen, Wei Liu, et al.
Journal of Molecular Endocrinology|February 16, 2012
Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signalingKathryn L Auld, Stephen P Berasi, Yan Liu, et al.
Molecular and Cellular Endocrinology|December 26, 2015
Deregulation of arginase induces bone complications in high-fat/high-sucrose diet diabetic mouse modelAnil Bhatta, Rajnikumar Sangani, Ravindra Kolhe, et al.
Circulation|June 3, 2011
Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocksJeffrey J Goldberger, Alfred E Buxton, Michael Cain, et al.
Bone|March 3, 2018
Amino acids as signaling molecules modulating bone turnoverKe-Hong Ding, Michael Cain, Michael Davis, et al.
Scientific Reports|October 7, 2023
A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetesJu Wang, Agustin Casimiro-Garcia, Bryce G Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Hit to lead studies on (hetero)arylpyrimidines--agonists of the canonical Wnt-beta-catenin cellular messaging systemAdam M Gilbert, Matthew G Bursavich, Nippa Alon, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Growth Factors (Chur, Switzerland)|June 28, 2011
Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinitiesStephen P Berasi, Usha Varadarajan, Joanne Archambault, et al.
Biochemistry|February 25, 2015
Characterization of binding mode of action of a blocking anti-platelet-derived growth factor (PDGF)-B monoclonal antibody, MOR8457, reveals conformational flexibility and avidity needed for PDGF-BB to bind PDGF receptor-βJun Kuai, Lidia Mosyak, Jon Brooks, et al.
Gene|February 6, 2007
Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signalingBheem M Bhat, Kristina M Allen, Wei Liu, et al.
Journal of Molecular Endocrinology|February 16, 2012
Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signalingKathryn L Auld, Stephen P Berasi, Yan Liu, et al.
Molecular and Cellular Endocrinology|December 26, 2015
Deregulation of arginase induces bone complications in high-fat/high-sucrose diet diabetic mouse modelAnil Bhatta, Rajnikumar Sangani, Ravindra Kolhe, et al.
Circulation|June 3, 2011
Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocksJeffrey J Goldberger, Alfred E Buxton, Michael Cain, et al.
Bone|March 3, 2018
Amino acids as signaling molecules modulating bone turnoverKe-Hong Ding, Michael Cain, Michael Davis, et al.
Scientific Reports|October 7, 2023
A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetesJu Wang, Agustin Casimiro-Garcia, Bryce G Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Hit to lead studies on (hetero)arylpyrimidines--agonists of the canonical Wnt-beta-catenin cellular messaging systemAdam M Gilbert, Matthew G Bursavich, Nippa Alon, et al.
Pageof 2